For budding entrepreneurs, award throws networking lifeline - Greater Wilmington Business Journal
| LLBO Stock | USD 0.0002 0.0001 100.00% |
About 54% of Lifeline Biotechnologies' investors are presently thinking to get in. The analysis of overall sentiment of trading Lifeline Biotechnologies pink sheet suggests that some investors are interested at this time. Lifeline Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Lifeline Biotechnologies. Many technical investors use Lifeline Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Lifeline |
For budding entrepreneurs, award throws networking lifeline Greater Wilmington Business Journal
Read at news.google.com
 |
Lifeline Biotechnologies Fundamental Analysis
We analyze Lifeline Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lifeline Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lifeline Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Lifeline Biotechnologies is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Lifeline Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lifeline Biotechnologies pink sheet to make a market-neutral strategy. Peer analysis of Lifeline Biotechnologies could also be used in its relative valuation, which is a method of valuing Lifeline Biotechnologies by comparing valuation metrics with similar companies.
Peers
Lifeline Biotechnologies Related Equities
| SSKN | STRATA Skin | 0.99 | ||||
| NPCE | Neuropace | 3.30 | ||||
| MODD | Modular Medical | 4.29 | ||||
| NXL | Nexalin Technology | 6.90 |
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.